Perceptions and Usability of PREVENTION: A Breast Cancer Risk Assessment e-Platform

Author:

Attieh Samar1,Monarque Marika23,Durand Andrew24,Ahmed Saima1ORCID,Knoppers Bartha M.5ORCID,Simard Jacques67ORCID,Loiselle Carmen G.1289ORCID

Affiliation:

1. Division of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H4A 3J1, Canada

2. Ingram School of Nursing, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 2M7, Canada

3. Department of Psychology, Faculty of Arts and Science, University of Montreal, Montreal, QC H2V 2S9, Canada

4. Department of Psychology, Faculty of Human Sciences, Université du Québec à Montréal, Montreal, QC H2X 1L7, Canada

5. Centre of Genomics and Policy, McGill University, Montréal, QC H3A 0G1, Canada

6. Department of Molecular Medicine, Faculty of Medicine, Université Laval, Quebec City, QC G1V 0A6, Canada

7. CHU de Québec-Université Laval Research Centre, Quebec City, QC G1V 4G2, Canada

8. Segal Cancer Centre, Jewish General Hospital, CIUSSS Centre-Ouest, Montreal, QC H3T 1E2, Canada

9. Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H4A 3T2, Canada

Abstract

Background: The PREVENTION e-platform was developed to provide accessible and evidence-based health information tailored to different Breast Cancer (BC) risk levels. The demonstration study objectives were to (1) assess the usability and perceived impact of PREVENTION on women with assigned hypothetical BC risk levels (i.e., near population, intermediate or high) and (2) explore perceptions and recommendations for e-platform improvement. Methods: Thirty women with no history of cancer were recruited through social media, commercial centers, health clinics, and community settings in Montreal, Qc, Canada. Participants accessed e-platform content tailored to their assigned hypothetical BC risk level, and then completed study e-questionnaires including the user Mobile Application Rating Scale (uMARS), an e-platform quality scale (i.e., in terms of engagement, functionality, aesthetics, and information). A subsample (n = 18) was randomly selected for an individual follow-up semi-structured interview. Results: The e-platform overall quality was high, with mean M = 4.01 (out of 5) and SD = 0.50. A total of 87% (n = 26) agreed or strongly agreed that PREVENTION increased their knowledge and awareness of BC risk, and 80% would recommend it to others while reporting likelihood of following lifestyle recommendations to decrease their BC risk. Follow up interviews indicated that participants perceived the e-platform as a trusted source of BC information and a promising means to connect with peers. They also reported that while the e-platform was easy to navigate, improvements were needed for connectivity, visuals, and the organization of scientific resources. Conclusion: Preliminary findings support PREVENTION as a promising means to provide personalized BC information and support. Efforts are underway to further refine the platform, assess its impact in larger samples and gather feedback from BC specialists.

Funder

Ministère de l’Économie, de la Science et de l’Innovation du Québec

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Reference38 articles.

1. The Global Breast Cancer Initiative: A strategic collaboration to strengthen health care for non-communicable diseases;Anderson;Lancet Oncol.,2021

2. Canadian Cancer Statistics Advisory Committee (2021). Canadian Cancer Statistics 2021, Canadian Cancer Society.

3. National Institute for Clinical Excellence (NICE) (2023, February 01). Familial Breast Cancer: Classification, Care and Managing Breast Cancer and Related Risks in People with a Family History of Breast Cancer (CG164). Published June 2013. Updated November 2019. Available online: https://www.nice.org.uk/guidance/cg164.

4. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk;Kapoor;J. Natl. Cancer Inst.,2021

5. Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States;Maas;JAMA Oncol.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3